After 17 years of despair, I’d been on 14 completely different antidepressant treatment combos and years of personal speak remedy. None of those remedies actually had any results and my situation continued to worsen.
Mark, Lived Expertise Skilled
Despair is among the main causes of unwell well being worldwide. In 2019, depressive problems have been among the many ten largest causes of years misplaced to unwell well being and early loss of life for each younger individuals and working-age adults (Vos et al, 2020). For a 3rd of individuals, their despair will likely be “troublesome to deal with” and they’ll proceed to expertise vital burden regardless of making an attempt first line remedies reminiscent of antidepressant drugs and group speaking therapies (Al-Harbi, 2012).
We now have lately held a webinar on the background and proof on a therapy for difficult-to-treat despair known as “transcranial magnetic stimulation” (TMS). TMS was really useful by NICE to be used inside the NHS in 2015 (NICE, 2015) though it is just out there in 1 in 7 psychological well being trusts at current (it’s extra broadly out there privately).
The webinar lined:
- The invention of TMS (trace: it’s a British invention!)
- Proof on medical and value effectiveness
- New approaches to enhance entry and availability of therapy
- Experiences of transcranial magnetic stimulation from three individuals with lived expertise of despair.
Right here I cowl a number of the proof on medical effectiveness and security of TMS in addition to ongoing analysis to enhance response charges and therapy accessibility. Hyperlinks to varied helpful sources are on the backside, as is a hyperlink to a survey we’re working to get some suggestions on perceptions of TMS from potential referrers (main care and psychological well being clinicians) that we are going to use to information our work on new TMS therapy pathways.
What’s TMS?
TMS is a kind of “neuromodulation” (non-invasive mind stimulation) therapy for despair. It makes use of magnetic pulses to re-balance exercise, and enhance flexibility (plasticity), inside and throughout mind networks (Downar et al, 2024). Sufferers come for a number of therapy classes per clinic go to over a couple of weeks for a complete of about thirty remedies. At every session, a therapy coil is positioned on their head (often over an space known as the left pre-frontal cortex). Every therapy is just round ten minutes of stimulation utilizing the most recent pulse sequences. The magnetic pulses trigger transient present stream inside focused mind areas. A affected person has TMS while they’re awake and alert. It’s completely different to “electroconvulsive remedy” (ECT) and doesn’t contain an anaesthetic or impression reminiscence.
The medical effectiveness of TMS
When NICE really useful TMS for despair in 2015, it based mostly this on 4 systematic evaluations displaying its medical efficacy. The biggest introduced collectively findings from 32 randomised managed trials (trials that examine lively TMS to inactive/sham/placebo TMS) (Lepping et al, 2014).
A 2019 evaluate introduced collectively 63 randomised managed trials in individuals with a present episode of despair (Mutz et al, 2019). A 2025 evaluate centered on 16 trials in individuals with treatment-resistant despair, which means despair that hasn’t responded to 2 or extra antidepressants (Saelens et al, 2025). Each discovered actual therapy labored higher than sham for the 2 kinds of stimulation most utilized in clinics: normal high-frequency stimulation and intermittent theta burst stimulation (Desk 1). Within the 2025 evaluate, theta burst stimulation ranked first out of 25 remedies for remission, forward of electroconvulsive remedy.
Two extra centered evaluations reported threat ratios, that are simpler to interpret (Vida et al, 2023; Kishi et al, 2024). They counsel actual therapy roughly doubles the possibility of response and remission in contrast with sham.
| Overview | Customary high-frequency stimulation | Intermittent theta burst stimulation |
|---|---|---|
| Mutz et al, 2019 Adults with a present episode of despair (unipolar or bipolar) | Response: OR 3.17 (2.29 to 4.37) Remission: OR 2.67 (1.79 to 4.00) | Response: OR 3.20 (1.45 to 7.08) Remission: OR 3.30 (1.38 to 7.90) Not vital as soon as excessive threat of bias trials have been eliminated |
| Saelens et al, 2025 Therapy-resistant unipolar despair | Response: OR 4.01 (2.36 to six.81) | Response: OR 4.80 (2.21 to 10.39) Ranked first of 25 remedies for remission |
| Vida et al, 2023 Despair after two failed antidepressants | Response: RR 2.25 (1.71 to 2.97) Remission: RR 2.78 (1.40 to five.53) | Not studied |
| Kishi et al, 2024 Adults with despair | Not studied | Response: RR 2.00 (1.28 to three.13) Remission: RR 2.16 (1.01 to 4.62) |
A 2018 trial that in contrast the 2 kinds of stimulation straight discovered theta burst was no much less efficient than normal stimulation (Blumberger et al, 2018), though some individuals might do higher with one than the opposite. The large benefit of theta burst is pace: a session takes 3 to 10 minutes, in contrast with 20 to 40 minutes for normal stimulation.
A big UK multi-centre trial of individuals with reasonable to extreme difficult-to-treat despair (with a median period of despair of 6 to 7 years) discovered that those that benefited may count on to remain nicely out to at the very least six months post-treatment (Morriss et al, 2024). (Some sufferers will keep nicely past this, while others may want a top-up course of TMS, or different remedies reminiscent of drugs, to remain nicely). That trial delivered twenty therapy classes per affected person. Some sufferers responded rapidly, however others confirmed a delayed response, suggesting longer therapy programs could also be helpful (Briley et al, 2024). Certainly, a retrospective case collection discovered a dose-response relationship with variety of therapy classes, out to thirty classes and past (Hutton et al, 2023).
Importantly, since individuals with difficult-to-treat despair usually have multi-factorial difficulties, transcranial magnetic stimulation might be readily mixed with different remedies, together with drugs and speaking therapies. A big US trial in contrast three subsequent steps for individuals whose antidepressant hadn’t labored: including transcranial magnetic stimulation, including an antipsychotic, or switching antidepressant (Papakostas et al, 2024). Including transcranial magnetic stimulation improved despair scores greater than switching (Desk 2). In one other trial, when given alongside cognitive behavioural remedy, transcranial magnetic stimulation was simpler than switching antidepressant (Dalhuisen et al, 2024).
| Subsequent step after an antidepressant hasn’t labored | Responded | Recovered (remission) |
|---|---|---|
| Add transcranial magnetic stimulation | 52% | 34% |
| Add an antipsychotic (aripiprazole) | 38% | 25% |
| Swap antidepressant | 36% | 25% |
I responded late into therapy, however they prolonged the therapy from the 20 to the 30 classes. And amazingly, I made a full restoration… I went from struggling to learn only a few paragraphs to being in educational examine.
Mark, Lived Expertise Skilled
The protection of TMS
TMS was invented on the College of Sheffield within the mid-Nineteen Eighties and so just isn’t a brand new therapy. Its first makes use of have been for neurological evaluation. American psychiatrists noticed the potential for treating despair and ran the primary giant multi-centre randomised managed trial twenty years in the past.
As a result of TMS makes use of magnetic fields, some individuals can not have TMS and a few precautions ought to be adopted (Trapp et al, 2025). There are comparable precautions to MRI mind scans, though the magnetic subject with TMS is way more focal than for MRI. Subsequently, specific considerations are conductive metallic or electronics close to the therapy coil. TMS makes a loud click on when it delivers a magnetic pulse, so sufferers and clinicians ought to put on ear plugs throughout a therapy session.
The 2 most severe unwanted effects are syncope (fainting) and seizure. Nonetheless, these are uncommon. Syncope is mostly early in a therapy course and in individuals who have beforehand skilled this for different causes (e.g., throughout blood assessments). In individuals with out epilepsy, the chance of a seizure is round 1 in 30,000 per session (1 in 1,400 throughout a complete therapy course) (Taylor et al, 2021). TMS employees are skilled to handle seizures and syncope and have protocols in place. In individuals with epilepsy, seizure threat has been estimated at 2 to three% throughout a therapy course, which must be factored into any concerns of dangers and advantages (Stultz et al, 2020).
Extra generally, individuals have delicate unwanted effects throughout or shortly after therapy, primarily scalp ache or discomfort and headache. A 2022 evaluate of 53 sham-controlled trials discovered these have been the one unwanted effects extra frequent with actual therapy than with sham (Wang et al, 2022). Desk 3 reveals how usually all sides impact occurs and what helps.
| Facet impact | How frequent | What helps |
|---|---|---|
| Scalp ache on the therapy website | 24% with actual therapy, 5% with sham | Normally settles over classes; small modifications to coil place or depth |
| Headache | 23% with actual therapy, 16% with sham | Typical over-the-counter painkillers |
| Scalp discomfort | 11% with actual therapy, 5% with sham | As for scalp ache |
| Loud click on with every pulse | Each session | Ear plugs for sufferers and employees |
| Fainting | Uncommon; principally early in a course, in individuals who have fainted earlier than | Workers skilled, with protocols in place |
| Seizure (individuals with out epilepsy) | About 1 in 30,000 classes, or 1 in 1,400 individuals over a course | Workers skilled, with protocols in place |
| Seizure (individuals with epilepsy) | About 2 to three% over a course | Dangers and advantages weighed up earlier than therapy |
Future instructions for TMS
Not everybody advantages from TMS. There are a number of the way being explored to assist extra sufferers get hold of extra profit extra rapidly (Peng et al, 2026). As already famous, higher profit can usually be achieved by delivering extra therapy classes. “Accelerated” approaches, which ship a number of therapy classes per day, can permit a therapy course to be delivered in a shorter timeframe (van Rooij et al, 2024).
Priming approaches might be able to enhance response or probably scale back the variety of therapy classes required. This consists of TMS priming, by which a unique (sometimes shorter) TMS pulse sequence is given in the beginning of every session to extend the responsivity of the mind to the primary therapy (this was one of the efficient neuromodulation approaches within the 2019 evaluate by Mutz et al).
Alternatively, one other kind of well-tolerated neuromodulation, transcranial direct present stimulation (tDCS), which makes use of weak electrical currents (sturdy sufficient to gentle up a small LED), might be able to prime TMS (Shickle et al, 2026). Priming approaches modify processes underlying mind plasticity, such that the mind turns into extra attentive to the consequences of TMS (“meta-plasticity”). There may be latest proof {that a} treatment that quickly modulates mind plasticity (D-cycloserine) may help to compress a TMS therapy course into one or two days (Vaughn et al, 2025).
In addition to decreasing the variety of therapy classes that sufferers require, approaches to extend therapy flexibility are wanted. One such method could possibly be a weekly therapy protocol, by which sufferers attend for a number of classes as soon as every week, maybe supported by psychotherapeutic actions (or digital therapeutics) which have been studied together with TMS (Dalhuisen et al, 2024), to enhance or lengthen efficacy. It could be attainable to ship a weekly therapy in a cellular clinic that visits completely different GP practices or well being hubs on completely different days, reaching individuals of their communities. We’re at the moment exploring the potential of this method.
It is going to be vital to make sure that new developments enhance, moderately than worsen, entry for underserved teams. Our latest survey discovered that consciousness of neuromodulation remedies is low, and that there are socio-demographic variations in perceptions of security and efficacy (Tan et al, 2026). Respondents recognized a number of potential boundaries to entry, but additionally methods to deal with these that ought to be integrated into therapy companies and future trials.
I’m one of many fortunate ones that has been supplied it and being out there to me in my area. So luck mustn’t come into it.
Matt, Lived Expertise Skilled
Discover out extra about TMS
Despair is among the most disabling situations confronted by individuals within the UK, and we’d like to have the ability to provide the total vary of efficient remedies. TMS is a secure and clinically and cost-effective therapy (Cox et al, 2026) and ought to be extra broadly out there on the NHS.
A hyperlink to our web site which incorporates the webinar and sources on the proof and security of TMS is at: https://mindtech.org.uk/analysis/research-themes/our-projects/tms-transcranial-magnetic-stimulation
Our web site a few new undertaking on approaches to reinforce response to TMS and enhance therapy accessibility (EnhanceTMS) is at: https://mindtech.org.uk/analysis/research-themes/our-projects/etms
The associated fee effectiveness of TMS will likely be lined in a future weblog.
Main care and psychological well being clinicians are invited to take our five-minute survey: we need to perceive perceptions of TMS amongst clinicians who may refer sufferers for therapy sooner or later. It will information our work creating new TMS therapy pathways. You may win a present voucher and obtain a certificates evidencing your engagement on this exercise: https://app.onlinesurveys.jisc.ac.uk/s/nottingham/tms-survey-clinicians
Watch our TMS movies and webinar
Assertion of curiosity
Paul Briley is a Consulting Neuroscience Specialist for The Science Behind, a division of Brainbox Ltd. He’s an writer of a number of research cited on this weblog (Briley et al, 2024; Morriss et al, 2024; Peng et al, 2026; Shickle et al, 2026; Tan et al, 2026) and is concerned within the EnhanceTMS undertaking.
Edited by
André Tomlin.
Proof for TMS: a brief bibliography
Abdelnaim MA, Langguth B, Deppe M. et al (2020) Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive sufferers: a retrospective evaluation of a big pattern. Frontiers in Psychiatry 2020 10 929. https://doi.org/10.3389/fpsyt.2019.00929
Al-Harbi KS (2012) Therapy-resistant despair: therapeutic traits, challenges, and future instructions. Affected person Desire and Adherence 2012 6 369-388. https://doi.org/10.2147/PPA.S29716
Blumberger DM, Vila-Rodriguez F, Thorpe KE. et al (2018) Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in sufferers with despair (THREE-D): a randomised non-inferiority trial. The Lancet 2018 391(10131) 1683-1692. https://doi.org/10.1016/S0140-6736(18)30295-2
Briley PM, Webster L, Lankappa S. et al (2024) Trajectories of enchancment with repetitive transcranial magnetic stimulation for treatment-resistant main despair within the BRIGhTMIND trial. npj Psychological Well being Analysis 2024 3(1) 32. https://doi.org/10.1038/s44184-024-00077-8
Cox E, Ma J, Roadevin C. et al (2026) Is it time for psychological well being companies to spend money on neurostimulation? An financial analysis of transcranial magnetic stimulation therapies for the therapy of reasonable to extreme treatment-resistant despair within the UK. BMJ Psychological Well being 2026 29(1) e302237. https://doi.org/10.1136/bmjment-2025-302237
Dalhuisen I, van Oostrom I, Spijker J. et al (2024) rTMS as a subsequent step in antidepressant nonresponders: a randomized comparability with present antidepressant therapy approaches. American Journal of Psychiatry 2024 181(9) 806-814. https://doi.org/10.1176/appi.ajp.20230556
Downar J, Siddiqi SH, Mitra A. et al (2024) Mechanisms of motion of TMS within the therapy of despair. Present Matters in Behavioral Neurosciences 2024 66 233-277. https://doi.org/10.1007/7854_2024_483
Hutton TM, Aaronson ST, Carpenter LL. et al (2023) Dosing transcranial magnetic stimulation in main depressive dysfunction: relations between variety of therapy classes and effectiveness in a big affected person registry. Mind Stimulation 2023 16(5) 1510-1521. https://doi.org/10.1016/j.brs.2023.10.001
Kishi T, Ikuta T, Sakuma Ok. et al (2024) Repetitive transcranial magnetic stimulation for bipolar despair: a scientific evaluate and pairwise and community meta-analysis. Molecular Psychiatry 2024 29(1) 39-42. https://doi.org/10.1038/s41380-023-02045-8
Kishi T, Ikuta T, Sakuma Ok. et al (2024) Theta burst stimulation for despair: a scientific evaluate and community and pairwise meta-analysis. Molecular Psychiatry 2024 29(12) 3893-3899. https://doi.org/10.1038/s41380-024-02630-5
Lepping P, Schönfeldt-Lecuona C, Sambhi RS. et al (2014) A scientific evaluate of the medical relevance of repetitive transcranial magnetic stimulation. Acta Psychiatrica Scandinavica 2014 130(5) 326-341. https://doi.org/10.1111/acps.12276
Morriss R, Briley PM, Webster L. et al (2024) Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant despair: a randomized managed trial. Nature Drugs 2024 30(2) 403-413. https://doi.org/10.1038/s41591-023-02764-z
Mutz J, Vipulananthan V, Carter B. et al (2019) Comparative efficacy and acceptability of non-surgical mind stimulation for the acute therapy of main depressive dysfunction in adults: systematic evaluate and community meta-analysis. BMJ 2019 364 l1079. https://doi.org/10.1136/bmj.l1079
NICE (2015) Repetitive transcranial magnetic stimulation for despair. HealthTech steering [HTG396]. London: Nationwide Institute for Well being and Care Excellence.
Papakostas GI, Trivedi MH, Shelton RC. et al (2024) Comparative effectiveness analysis trial for antidepressant incomplete and non-responders with therapy resistant despair (ASCERTAIN-TRD): a randomized medical trial. Molecular Psychiatry 2024 29(8) 2287-2295. https://doi.org/10.1038/s41380-024-02468-x
Peng Y, Webster L, Lankappa S. et al (2026) Augmentation methods for transcranial magnetic stimulation (TMS) within the therapy of unipolar despair: a scoping evaluate. Journal of Affective Issues Experiences 2026 25 101058. https://doi.org/10.1016/j.jadr.2026.101058
Saelens J, Gramser A, Watzal V. et al (2025) Relative effectiveness of antidepressant remedies in treatment-resistant despair: a scientific evaluate and community meta-analysis of randomized managed trials. Neuropsychopharmacology 2025 50(6) 913-919. https://doi.org/10.1038/s41386-024-02044-5
Shickle J, Axford A, Tan SF. et al (2026) Combining transcranial electrical and magnetic stimulation: a scoping evaluate of neurophysiological and medical research. Medical Neurophysiology 2026 2112437. https://doi.org/10.1016/j.clinph.2026.2112437
Stultz DJ, Osburn S, Burns T. et al (2020) Transcranial magnetic stimulation (TMS) security with respect to seizures: a literature evaluate. Neuropsychiatric Illness and Therapy 2020 16 2989-3000. https://doi.org/10.2147/NDT.S276635
Tan SF, Shickle J, Webster L. et al (2026) Potential acceptability and boundaries to uptake for non-invasive mind stimulation for psychological well being therapy: a co-produced nationwide survey of individuals with lived expertise of psychological well being situations. Analysis Sq. 2026 (preprint). https://doi.org/10.21203/rs.3.rs-9814760/v1
Taylor JJ, Newberger NG, Stern AP. et al (2021) Seizure threat with repetitive TMS: survey outcomes from over a half-million therapy classes. Mind Stimulation 2021 14(4) 965-973. https://doi.org/10.1016/j.brs.2021.05.012
Trapp NT, Purgianto A, Taylor JJ. et al (2025) Consensus evaluate and concerns on TMS to deal with despair: a complete replace endorsed by the Nationwide Community of Despair Facilities, the Medical TMS Society, and the Worldwide Federation of Medical Neurophysiology. Medical Neurophysiology 2025 170 206-233. https://doi.org/10.1016/j.clinph.2024.12.015
van Rooij SJH, Arulpragasam AR, McDonald WM. et al (2024) Accelerated TMS: transferring rapidly into the way forward for despair therapy. Neuropsychopharmacology 2024 49(1) 128-137. https://doi.org/10.1038/s41386-023-01599-z
Vaughn DA, Marino B, Engelbertson A. et al (2025) Actual-world effectiveness of a single-day routine for transcranial magnetic stimulation utilizing Optimized, Neuroplasticity-Enhanced strategies in Despair (ONE-D): an open-label case collection. Transcranial Magnetic Stimulation 2025 5 100200. https://doi.org/10.1016/j.transm.2025.100200
Vida RG, Sághy E, Bella R. et al (2023) Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive remedy for main depressive dysfunction (MDD) after two antidepressant therapy failures: meta-analysis of randomized sham-controlled trials. BMC Psychiatry 2023 23(1) 545. https://doi.org/10.1186/s12888-023-05033-y
Vos T, Lim SS, Abbafati C. et al (2020) International burden of 369 illnesses and accidents in 204 international locations and territories, 1990-2019: a scientific evaluation for the International Burden of Illness Examine 2019. The Lancet 2020 396(10258) 1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Wang W-L, Wang S-Y, Hung H-Y. et al (2022) Security of transcranial magnetic stimulation in unipolar despair: a scientific evaluate and meta-analysis of randomized-controlled trials. Journal of Affective Issues 2022 301 400-425. https://doi.org/10.1016/j.jad.2022.01.047
